CRISPR‒Cas9 gene mutation of CCR2 in MCF10CA1d cells inhibited tumor growth and TAM recruitment, which was also observed by Ccr2 shRNA knockdown in the mouse 4T1 TNBC model. Here, CCR2 is linked to neoplasm.